NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9480	Companies
185527	Keywords
117915	Articles
99372	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 05/28/2024 at 22:20, 1 year 6 months ago

NANOBIOTIX Presents New Data at ASCO 2024

Immunotherapy NANOBIOTIX NBTXR3 ASCO Phase 1
PRESS RELEASE

published on 05/28/2024 at 22:15, 1 year 6 months ago

NANOBIOTIX annonce une présentation de nouvelles données et du programme d’immunothérapie de Phase 1 lors de la réunion annuelle 2024 de l’American Society for Clinical Oncology (ASCO) suivi d’une conférence téléphonique et webcast
Nanobiotix annonce la présentation de nouvelles données et du programme d'immunothérapie de phase 1 lors de la réunion annuelle 2024 de l'ASCO, suivi d'une conférence téléphonique et webcast

Immunothérapie Cancer ASCO 2024 NANOBIOTIX NBTXR3
PRESS RELEASE

published on 05/28/2024 at 22:15, 1 year 6 months ago

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
Nanobiotix to present new data from Phase 1 immunotherapy program at 2024 ASCO meeting followed by investor conference call. Details for the call provided

Investor Conference Call Immunotherapy ASCO 2024 NANOBIOTIX Phase 1
BRIEF

published on 05/23/2024 at 22:20, 1 year 6 months ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

Biotechnology Cancer Treatment Webcast NANOBIOTIX Jefferies Global Healthcare Conference
BRIEF

published on 05/23/2024 at 22:20, 1 year 6 months ago

NANOBIOTIX fera une présentation à la conférence Jefferies Global Healthcare

Biotechnologie Webdiffusion Traitement Du Cancer NANOBIOTIX Conférence Mondiale Jefferies Sur Les Soins De Santé
PRESS RELEASE

published on 05/23/2024 at 22:15, 1 year 6 months ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Nanobiotix to present at the Jefferies Global Healthcare Conference on June 5, 2024, with Bart Van Rhijn, CFO, participating in a fireside chat. Company pioneering physics-based approaches for cancer treatment

Cancer Treatment Biotechnology Company NANOBIOTIX Jefferies Global Healthcare Conference Physics-based Approaches
PRESS RELEASE

published on 05/23/2024 at 22:15, 1 year 6 months ago

NANOBIOTIX participera à la conférence Jefferies Global Healthcare
Nanobiotix participera à la conférence Jefferies Global Healthcare pour discuter de ses avancées en biotechnologie. Détails de l'événement et webcast disponibles

Biotechnologie Traitement Cancer NANOBIOTIX Conférence Jefferies
BRIEF

published on 05/21/2024 at 22:20, 1 year 6 months ago

Nanobiotix Announces Advancement in NBTXR3 Development and Strategic Collaboration

Biotechnology Cancer Therapy NANOBIOTIX NBTXR3 Janssen Collaboration
BRIEF

published on 05/21/2024 at 22:20, 1 year 6 months ago

Nanobiotix annonce des progrès dans le développement de NBTXR3 et une collaboration stratégique

Biotechnologie Thérapie Contre Le Cancer NANOBIOTIX NBTXR3 Collaboration Janssen
PRESS RELEASE

published on 05/21/2024 at 22:15, 1 year 6 months ago

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
Nanobiotix announces progress in global NBTXR3 development collaboration, highlighting robust pipeline and pathway to long-term growth in cancer treatment. Updates include US FDA approvals and strategic study modifications

Cancer Treatment NANOBIOTIX NBTXR3 Global Development FDA Approvals

Accesswire

Published on 12/05/2025 at 18:45, 16 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 41 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 1 minute ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 46 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 2 hours 1 minute ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 3 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 34 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 45 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 9 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 15 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 43 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 43 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 50 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 50 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 2 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE